David Coeffic
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 19
- HER2/EGFR in Cancer Research 9
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 2
-
- Breast Cancer Treatment Studies 8
- Co-authors
- David Khayat (9 shared papers)Laurent Arnould (5 shared papers)Bruno P. Coudert (4 shared papers)Éric-Charles Antoine (6 shared papers)Mario Campone (3 shared papers)Frank Priou (2 shared papers)Veronique N. Trillet-Lenoir (2 shared papers)Thomas Bachelot (5 shared papers)
In The Last Decade
David Coeffic
33 papers receiving 709 citations
Peers
Comparison fields: 5 of 52
- Oncology 335
- Cancer Research 184
- Reproductive Medicine 48
- Radiology, Nuclear Medicine and Imaging 81
- Geriatrics and Gerontology 11
Countries citing papers authored by David Coeffic
This map shows the geographic impact of David Coeffic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Coeffic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Coeffic more than expected).
Fields of papers citing papers by David Coeffic
This network shows the impact of papers produced by David Coeffic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Coeffic. The network helps show where David Coeffic may publish in the future.
Co-authors
The 25 scholars most cited alongside David Coeffic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 112 | |
| 2 | 2014 | 112 | |
| 3 | 2019 | 105 | |
| 4 | 2021 | 63 | |
| 5 | 2017 | 44 | |
| 6 | 2000 | 39 | |
| 7 | 2011 | 32 | |
| 8 | 2012 | 29 | |
| 9 | 2016 | 25 | |
| 10 | 2001 | 23 | |
| 11 | 2012 | 23 | |
| 12 | 2010 | 18 | |
| 13 | 2011 | 14 | |
| 14 | 2015 | 14 | |
| 15 | 2006 | 12 | |
| 16 | 2020 | 9 | |
| 17 | Non-small cell lung cancer: slow but definite progress. | 1996 | 7 |
| 18 | Chemotherapy and chemoimmunotherapy for metastatic malignant melanoma: review and recent advances. | 2000 | 6 |
| 19 | 2023 | 6 | |
| 20 | European experience with irinotecan plus fluorouracil/folinic acid or mitomycin. | 1998 | 5 |
About David Coeffic
David Coeffic is a scholar working on Oncology, Cancer Research, Reproductive Medicine, Complementary and alternative medicine and Pathology and Forensic Medicine, having authored 37 papers that have together received 738 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Breast Cancer Treatment Studies (8 papers), Ovarian cancer diagnosis and treatment (5 papers), Cancer Treatment and Pharmacology (5 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer therapeutics and mechanisms (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (335 citations), Cancer Research (184 citations), Reproductive Medicine (48 citations), Radiology, Nuclear Medicine and Imaging (81 citations) and Geriatrics and Gerontology (11 citations). David Coeffic has collaborated with scholars based in France, Belgium and Australia. Frequent co-authors include David Khayat, Laurent Arnould, Bruno P. Coudert, Éric-Charles Antoine, Mario Campone, Frank Priou, Veronique N. Trillet-Lenoir, Thomas Bachelot, Joseph Gligorov and Beatrice E. Weber. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology, The Lancet and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.